Scholar Rock is a biopharmaceutical company specializing in discovering and developing innovative therapies for serious diseases with high unmet needs. Focused on the biology of transforming growth factor beta (TGFβ) superfamily proteins, Scholar Rock has created a pipeline targeting neuromuscular disease, cardiometabolic disorders, cancer, and other conditions. The company is distinguished by its proprietary platform that develops novel monoclonal antibodies for precise protein growth factor modulation, offering transformative treatments like muscle-targeted therapies for spinal muscular atrophy (SMA).
Scholar Rock is seeking a Director of Program Management to serve as the primary operational partner for the Myostatin Core Team. The ideal candidate has experience transitioning a program from late-stage development to commercial support and possesses a hybrid skillset of regulatory and commercial knowledge.
Scholar Rock is a biopharmaceutical company specializing in discovering and developing innovative therapies for serious diseases with high unmet needs. Focused on the biology of transforming growth factor beta (TGFβ) superfamily proteins, Scholar Rock has created a pipeline targeting neuromuscular disease, cardiometabolic disorders, cancer, and other conditions. The company is distinguished by its proprietary platform that develops novel monoclonal antibodies for precise protein growth factor modulation, offering transformative treatments like muscle-targeted therapies for spinal muscular atrophy (SMA).
Scholar Rock